LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 787-793

  Mahadik, Mahadeo ^a   Bhusari, Vidhya ^a   Kulkarni, Mahesh ^b   Dhaneshwar, Sunil ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

HPLC; Stability indicating method; Stress studies; Tenatoprazole; Validation

Indexed keywords

BENATOPRAZOLE;

ARTICLE; CONTROLLED STUDY; DECOMPOSITION; DEGRADATION KINETICS; HUMIDITY; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TEMPERATURE SENSITIVITY; ULTRAVIOLET SPECTROSCOPY;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HOT TEMPERATURE; HYDROGEN PEROXIDE; HYDROLYSIS; IMIDAZOLES; MASS SPECTROMETRY; MODELS, CHEMICAL; OMEPRAZOLE; OXYGEN; PHOTOCHEMISTRY; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE;

EID: 70349163603     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.06.026     Document Type: Article

References (12)

1. Scarpignato C., and Pelosini I. Review article: the opportunities and benefits of extended acid suppression. Aliment. Pharmacol. Ther. 23 (2006) 23-34
2. Guan J., Yang J., Bi Y., Shi S., and Li F. Chiral separation of tenatoprazole enantiomers using high performance liquid chromatography on vacomycin-bonded chiral stationary phase. Se Pu 25 (2007) 732-734
3. +-ATPase inhibitor, on gastric acid secretion in dogs. J. Pharm. Pharmacol. 51 (1999) 457-464
4. Chun A.H., Erdman K., Zhang Y., Achari R., and Cavanaugh J.H. Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods. Clin. Ther. 22 (2000) 231-236
5. Larson C., Cavuto N.J., Flockhart D.A., and Weinberg R.B. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube. Dig. Dis. Sci. 41 (1996) 475-479
6. Galmiche J.P., Varannes S.B., Ducrotte P., Sacher-Huvelin S., Vavaseur F., Taccoen A., Fiorentini P., and Homerin M. Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers. Aliment. Pharmacol. Ther. 19 (2004) 655-662
7. Nirogi R., Kandikere V., Mudigonda K., and Bhyrapuneni G. Quantification of tenatoprazole in rat plasma by HPLC: validation and its application to pharmacokinetic studies. Biomed. Chromatogr. 21 (2007) 1240-1244
8. Liu P., Sun B., Lu X., Qin F., and Li F. HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule. Biomed. Chromatogr. 21 (2007) 89-93
9. Domagala F., Ficheux H., Houin G., and Barre J. Pharmacokinetics of tenatoprazole, a newly synthesized proton pump inhibitor, in healthy male Caucasian volunteers. ArzneimittelForschung 56 (2006) 33-39
10. Stability Testing of New Drugs Substances and Products, Proceedings of the International Conference on Harmonization (ICH), IFPMA, Geneva, Switzerland, 2002.
11. ICH, Q2 (R1) Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva, 2005.
12. Lindberg P., Brandstrom A., Wallmark B., Mattsson H., Rikner L., and Hoffman K. Omeprazole: the first proton pump inhibitor. Med. Res. Rev. 10 (1990) 1-54